ViaDerma Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
213.80
130.90
191.80
252.00
44.70
46
Cost of Goods Sold (COGS) incl. D&A
107.40
49.20
11.00
11.70
8.00
21.50
Gross Income
106.40
81.60
180.80
240.30
36.70
24.50
SG&A Expense
45.50
6,287.10
87.10
112.80
630.10
1,710.90
EBIT
60.90
6,205.50
93.80
127.50
593.40
1,686.40
Unusual Expense
56.20
106.90
52.70
0.60
533.20
8.40
Interest Expense
82.70
161.30
119.30
249.80
391.70
421
Pretax Income
78.00
6,473.70
27.10
121.80
1,518.40
2,115.80
Consolidated Net Income
78.00
6,473.70
27.10
121.80
1,518.40
2,115.80
Net Income
78.00
6,473.70
27.10
121.80
1,518.40
2,115.80
Net Income After Extraordinaries
78.00
6,473.70
27.10
121.80
1,518.40
2,115.80
Net Income Available to Common
78.00
6,473.70
27.10
121.80
1,518.40
2,115.80
EPS (Basic)
6.00
0.11
0.00
0.00
0.00
-
Basic Shares Outstanding
13.20
57,385.70
103,679.20
160,802.40
376,239.40
609,641.10
EPS (Diluted)
5.89
0.11
0.00
0.00
0.00
-
Diluted Shares Outstanding
13.20
57,385.70
103,679.20
160,802.40
376,239.40
609,641.10
EBITDA
61.40
6,204.50
94.70
128.40
592.40
1,685.90
About ViaDerma
View Profile
